Klio Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24303TG2020PTC139831 Incorporated 16 March 2020 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma DPIIT Startup MSME · Micro
Data last updated
Revenue · FY 2023
₹8.14 Cr
▲ 2356% YoY
Net loss · FY 2023
₹1.67 Cr
Net margin -20.5%
EBITDA · FY 2023
-₹1.66 Cr
EBITDA margin -20.4%
Authorised capital
₹9 Cr
Registered with MCA
Paid-up capital
₹4.77 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
19
Provident fund records
Directors on board
3
As per MCA filings

About Klio Pharma Private Limited

Data last updated:

Klio Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24303TG2020PTC139831. Its GSTIN is 36AAICK0566G1ZI (Telangana).

The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹4.77 Cr. It is led by directors including Surendranath Benerjee Sunkavalli and Venkat Ramana Sunkavalli.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2023, the company reported a revenue of ₹8.14 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.67 Cr (net margin -20.5%) and EBITDA of -₹1.66 Cr (EBITDA margin -20.4%).

The company has about 19 employees on its provident fund (EPFO) records.

Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.

Klio Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0015453). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kliopharma.in.

Company details

CIN U24303TG2020PTC139831
Registration Number 139831
Incorporation Date 16 March 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0015453

Recognitions & Rankings of Klio Pharma

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0015453

Contact details

Klio Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is kliopharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No.75 Aleap Industrial Estate, Pragathi Nagar Road No.7, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Klio Pharma Private Limited, buy the company report.

Comprehensive company report
Klio Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Klio Pharma Private Limited

FY 2023 filings available

Klio Pharma Private Limited reported revenue of ₹8.14 Cr (up 2356% YoY) for FY 2023.

Revenue · FY 2023
₹8.14 Cr ▲ 2356%
Net loss · FY 2023
₹1.67 Cr margin -20.5%
EBITDA · FY 2023
-₹1.66 Cr margin -20.4%

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹8.14 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.66 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.67 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-20.4%
Net Profit Margin-20.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Klio Pharma Private Limited, buy the company report.

Board of directors of Klio Pharma Private Limited

Klio Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Surendranath Benerjee SunkavalliDirector16 Mar 20206 Years 7 MonthsCurrent
Vinay ThimmineniAdditional Director05 Dec 20241 Years 10 MonthsCurrent
Venkat Ramana SunkavalliDirector02 Jan 20215 Years 9 MonthsCurrent

Auditor

Klio Pharma Private Limited is audited by Naveen Madivada and Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Naveen Madivada and CoFY 2023016816S

Shareholding

The shareholding of Klio Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Klio Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Klio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Klio Pharma Private Limited has a workforce of 19 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
19
Active EPFO establishments
1

GST

Klio Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAICK0566G1ZITelanganaActive09 Jun 2020

To see the full GST registrations and return filing status of Klio Pharma Private Limited, buy the company report.

Recent activity

Klio Pharma Private Limited has 11 board changes on record since 2020: 7 appointments and 4 cessations. The latest: Vinay Thimmineni was appointed as Additional Director on 05 Dec 2024.

AGM
Klio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Vinay Thimmineni was appointed as Additional Director.
Ceased
Aditya Varma Sayyaparaju ceased to be Director.
Ceased
Mahesh Ventrapati ceased to be Director.
Ceased
Satish Kalidindi ceased to be Director.
Ceased
Sayyaparaju Venkata Satya Surya Sita Rama Raju ceased to be Director.
Filing
Klio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Appointed
Mahesh Ventrapati was appointed as Director.
Appointed
Aditya Varma Sayyaparaju was appointed as Director.
Appointed
Sayyaparaju Venkata Satya Surya Sita Rama Raju was appointed as Director.
Appointed
Venkat Ramana Sunkavalli was appointed as Director.
Appointed
Satish Kalidindi was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Klio Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2020 (6+ years old) and is registered under CIN U24303TG2020PTC139831.

Klio Pharma has 3 current directors:

The latest financial statements of Klio Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Klio Pharma is 36AAICK0566G1ZI, registered in Telangana.

The CIN (Corporate Identification Number) of Klio Pharma is U24303TG2020PTC139831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Klio Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.

Klio Pharma was incorporated on 16 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.

Vinay Thimmineni was appointed as Additional Director on 05 Dec 2024. Aditya Varma Sayyaparaju ceased to be Director on 24 Nov 2023. Mahesh Ventrapati ceased to be Director on 24 Nov 2023. Klio Pharma has 11 board changes on record in total.

Yes, Klio Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Klio Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0015453).